Monday, August 2, 2021

Health Ministry finalises advance arrangement with Biological-E Ltd, Hyderabad for 30 cr COVID-19 Vaccine doses

The Ministry of Health has finalized arrangements with Hyderabad-based vaccine manufacturer Biological-E to reserve 30 crore doses of COVID-19 vaccine. These vaccine doses will be manufactured and stockpiled by Biological-E from August to December 2021. For this purpose, the Union Ministry of Health would be making an advance payment of Rs. 1500 crore to Biological-E.

After exhibiting promising results in phase 1 and 2 clinical trials, the Biological-E’s COVID-19 vaccine is presently undergoing phase 3 clinical trials. The vaccine being developed by Biological-E is an RBD protein sub-unit vaccine and is expected to be available in the next few months.
The proposal of Biological-E was examined and recommended for approval after due diligence by the National Expert Group on Vaccine Administration for COVID-19 (NEGVAC).

The agreement with Biological-E is part of the Indian government’s larger effort to promote indigenous vaccine makers by providing them support in research and development (R&D) as well as financial assistance.

The government of India has supported the Biological-E COVID vaccine candidates from preclinical to phase 3 studies. The Department of Biotechnology has not only provided financial support in terms of grant-in-aid of over Rs 100 crore, but it has also collaborated with Biological-E to undertake all animal challenge and assay studies through its Research Institute Translational Health Science Technology Institute (THSTI), Faridabad.

This has been undertaken under the Government of India’s Mission COVID Suraksha- the Indian COVID-19 vaccine development mission, which was launched as part of the third stimulus package, Atmanirbhar 3.0, to boost and accelerate COVID-19 vaccine development efforts.

The Mission’s major goal is to bring to the citizens a safe, efficacious, affordable, and accessible COVID-19 Vaccine. The mission is to support the development of 5-6 COVID-19 vaccine candidates. Some of these are now closer to avail license and from being introduced in public health systems. It has not just hastened the COVID-19 vaccine development efforts, but also fostered a robust end-to-end vaccine development ecosystem in the nation that will be available for other ongoing and future research and developmental activities for other vaccines.

- Advertisement -
Latest news

Women’s Hockey: Thank You, Girls! History has been made

Indian Women’s Hockey Team on Monday carved its name in history as they entered the semi-finals of the Olympic Games for the first time...

Centre rushes multi-disciplinary team to Maharashtra to monitor Zika virus situation

The Centre has rushed a multi-disciplinary team to Maharashtra to monitor the Zika virus situation and support the State Government in the management of...

DRDO has developed state-of-art platforms and weapon systems and sensors to improve combat capabilities and technological edge to armed forces: Union Minister Ajay Bhatt

Defence Research and Development Organisation (DRDO) has developed state-of-art platforms and weapon systems and sensors to improve the combat capabilities and technological edge to...

Sensex climbs 364 points, Nifty settles at 15,885

The Sensex and the Nifty on Monday gained more than half a per cent. Both equity indices appreciated amid positive global cues. The BSE Sensex...
Related news

Women’s Hockey: Thank You, Girls! History has been made

Indian Women’s Hockey Team on Monday carved its name in history as they entered the semi-finals of the Olympic Games for the first time...

Centre rushes multi-disciplinary team to Maharashtra to monitor Zika virus situation

The Centre has rushed a multi-disciplinary team to Maharashtra to monitor the Zika virus situation and support the State Government in the management of...

DRDO has developed state-of-art platforms and weapon systems and sensors to improve combat capabilities and technological edge to armed forces: Union Minister Ajay Bhatt

Defence Research and Development Organisation (DRDO) has developed state-of-art platforms and weapon systems and sensors to improve the combat capabilities and technological edge to...

Sensex climbs 364 points, Nifty settles at 15,885

The Sensex and the Nifty on Monday gained more than half a per cent. Both equity indices appreciated amid positive global cues. The BSE Sensex...